[4] Hawton, et al. Suicide and Attempted Suicide in Bipolar Disorder: A Symptomatic Review of Risk Factors. J Clin Psychiatry. 2005;66:693-704.
[5] MacFadden W, Minkwitz, Spong E. Quetiapine monotherapy demonstrate efficacy in reducing suicidality in bipolar depression. Poster presented at the American Psychiatric Association Annual Meeting, Toronto, 2006.
[6] Lydiard BR, Raines S, Macfadden W. Improvement in anxiety symptoms in bipolar depression with quetiapine monotherapy: results from two placebo-controlled studies. Presented at the American Psychiatric Association Annual Meeting, Toronto, 2006.
[7] Hirschfeld RM, Suppes T, Vieta E et al. Quetiapine monotherapy for bipolar II depression: Pooled results from two placebo-controlled studies. Presented at the American Psychiatric Association Annual Meeting, Toronto, 2006.
James Read, AstraZeneca, Tel: +1-302-885-9944 or mobile +1-302-750-7356, Email: James.Read@astrazeneca.com; Maren Koban, Hill&Knowlton, Tel: +44-207-973-4497 or mobile +44-7713-631-514, Email: mkoban@hillandknowlton.com
